About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD11.7996804300143.2378
Domestic EquitiesAUROBINDO PHARMA LTD7.707174100093.5587
Domestic EquitiesLUPIN LTD6.930441024084.1300
Domestic EquitiesCIPLA LTD6.191649000075.1611
Domestic EquitiesDR REDDYS LABORATORIES LTD6.086761455573.8879
Domestic EquitiesDIVI LABORATORIES LTD5.337410496564.7917
Domestic EquitiesFORTIS HEALTHCARE LTD4.643585510056.3682
Domestic EquitiesZYDUS LIFESCIENCES LTD3.750247128745.5240
Domestic EquitiesALKEM LABORATORIES LTD3.49777524942.4589
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD3.31365890340.2243
Domestic EquitiesWOCKHARDT LTD3.179727487138.5988
Domestic EquitiesASTER DM HEALTHCARE LTD2.705865699132.8463
Domestic EquitiesORCHID PHARMA LTD2.416817500029.3379
Domestic EquitiesLAURUS LABS LTD2.359450500028.6411
Domestic EquitiesAJANTA PHARMA LTD2.35899473728.6347
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD2.343056612128.4419
Domestic EquitiesMEDI ASSIST HEALTHCARE SERVICES LTD2.055441867024.9506
Domestic EquitiesFDC LTD1.986647128324.1156
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.94217092123.5756
Domestic EquitiesIPCA LABORATORIES LTD1.810214245221.9739
Domestic EquitiesINDOCO REMEDIES LTD1.784366699221.6606
Domestic EquitiesJUPITER LIFE LINE HOSPITALS LTD1.325710638916.0924
Domestic EquitiesPIRAMAL PHARMA LTD1.321059670216.0364
Domestic EquitiesAKUMS DRUGS AND PHARMACEUTICALS LTD1.282825735215.5724
Domestic EquitiesSANOFI INDIA LTD1.00891916412.2468
Domestic EquitiesCOROMANDEL INTERNATIONAL LTD0.88426000010.7340
Domestic EquitiesAMI ORGANICS LTD0.88275000010.7148
Domestic EquitiesMANKIND PHARMA LTD0.87444144610.6151
Domestic EquitiesSYNGENE INTERNATIONAL LTD0.829610704610.0709
Domestic EquitiesMEDPLUS HEALTH SERVICES LTD0.76601188089.2991
Domestic EquitiesSANOFI CONSUMER HEALTHCARE INDIA LTD0.7618191649.2474
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD0.6824160008.2833
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD0.4951245886.0103
Domestic EquitiesDEEPAK NITRITE LTD0.4023179094.8842
Total 95.7167 1161.9267
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET3.9624 48.1000
Cash & Cash Equivalents and Net AssetsA) REPO0.3210 3.8961
Total 4.2833 51.9961
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.